Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores the need for rapid molecular diagnostics to improve outcomes.
Immunic to Participate in Scientific Conferences in October – Biotech Investments
Issuer: Immunic, Inc. / Key word(s): Conference 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate